S607-0071 Screening compound: 3-[1-(cyclopent-3-ene-1-carbonyl)piperidin-3-yl]-1-methyl-1H,2H,3H-imidazo[4,5-b]pyridin-2-one

S607-0071 Screening compound: 3-[1-(cyclopent-3-ene-1-carbonyl)piperidin-3-yl]-1-methyl-1H,2H,3H-imidazo[4,5-b]pyridin-2-one
S607-0071 Screening compound: 3-[1-(cyclopent-3-ene-1-carbonyl)piperidin-3-yl]-1-methyl-1H,2H,3H-imidazo[4,5-b]pyridin-2-one alternative view

Chemical Structure Depiction of ChemDiv screening compound S607-0071
3-[1-(cyclopent-3-ene-1-carbonyl)piperidin-3-yl]-1-methyl-1H,2H,3H-imidazo[4,5-b]pyridin-2-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S607-0071

Molecular Formula

C18H22N4O2 (C18 H22 N4 O2)

Compound Name

3-[1-(cyclopent-3-ene-1-carbonyl)piperidin-3-yl]-1-methyl-1H,2H,3H-imidazo[4,5-b]pyridin-2-one

IUPAC name

3-[(3S)-1-(cyclopent-3-ene-1-carbonyl)piperidin-3-yl]-1-methyl-1H2H3H-imidazo[45-b]pyridin-2-one

SMILES

CN(c1c(N2[C@@H](CCC3)CN3C(C3CC=CC3)=O)nccc1)C2=O

InChI

InChI=1S/C18H22N4O2/c1-20-15-9-4-10-19-16(15)22(18(20)24)14-8-5-11-21(12-14)17(23)13-6-2-3-7-13/h2-4,9-10,13-14H,5-8,11-12H2,1H3/t14-/m0/s1

InChI Key

CHHBJADBGSTHKF-AWEZNQCLSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

326.4

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

1.765

Distribution Coefficient, logD

1.765

Water Solubility, LogSw

-1.80

Polar Surface Area

44.386

Acid Dissociation Constant (pKa)

21.92

Base Dissociation Constant (pKb)

1.38

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

50.00

S607-0071 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

CNS MPO Library (28609 compounds)

GPCR Targeted Library (31838 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S607-0071 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S607-0071?
Check Price and Availability of S607-0071, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S607-0071 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S607-0071
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S607-0071
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S607-0071 available by request